Dejan B Budimirovic

Assistant Professor

20062018
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2006 2018

Filter
Review article
2018

Clinical development of targeted fragile X syndrome treatments: An industry perspective

Lee, A. W., Ventola, P., Budimirovic, D. B., Berry-Kravis, E. & Visootsak, J., Dec 1 2018, In : Brain Sciences. 8, 12, 214.

Research output: Contribution to journalReview article

Fragile X Syndrome
Industry
Fragile X Mental Retardation Protein
Intellectual Disability
Clinical Trials
2017

Fragile X syndrome: Lessons learned from the most translated neurodevelopmental disorder in clinical trials

Duy, P. Q. & Budimirovic, D. B., 2017, In : Translational Neuroscience. 8, 1, p. 7-8 2 p.

Research output: Contribution to journalReview article

Fragile X Syndrome
Clinical Trials
Intellectual Disability
Neurodevelopmental Disorders
Therapeutics

Fragile X targeted pharmacotherapy: Lessons learned and future directions

Erickson, C. A., Davenport, M. H., Schaefer, T. L., Wink, L. K., Pedapati, E. V., Sweeney, J. A., Fitzpatrick, S. E., Brown, W. T., Budimirovic, D. B., Hagerman, R. J., Hessl, D., Kaufmann, W. E. & Berry-Kravis, E., Jun 12 2017, In : Journal of Neurodevelopmental Disorders. 9, 1, 7.

Research output: Contribution to journalReview article

Fragile X Syndrome
Drug Therapy
Pharmaceutical Preparations
Clinical Trials
Direction compound

Updated report on tools to measure outcomes of clinical trials in fragile X syndrome

Budimirovic, D. B., Berry-Kravis, E., Erickson, C. A., Hall, S. S., Hessl, D., Reiss, A. L., King, M. K., Abbeduto, L. & Kaufmann, W. E., Jun 12 2017, In : Journal of Neurodevelopmental Disorders. 9, 1, 14.

Research output: Contribution to journalReview article

Fragile X Syndrome
Outcome Assessment (Health Care)
Clinical Trials
National Institutes of Health (U.S.)
United States Food and Drug Administration